EUVIMEDEUVIMED entdecken
Crossref

Synthesis, Quality Control, and Bench-to-Bed Translation of a New [ 68 Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography

Sudipta Chakraborty iD, Sucheta Chatterjee, Rubel Chakravarty, Haldhar D Sarma, Raviteja Nanabala, Dibakar Goswami, Ajith Joy, Maroor Raghavan Ambikalamajan Pillai

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2023.0077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Sudipta Chakraborty und 7 weiteren Autor:innen. Beteiligte Einrichtung: Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai, India. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Gallium Radioisotopes, Heterocyclic Compounds, 1-Ring. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early detection of skeletal metastasis is of great interest to determine the prognosis of cancer. Positron emission tomography-computed tomography (PET-CT) imaging provides a better temporal and spectral resolution than single photon emission computed tomography-computed tomography (SPECT-CT) imaging, and hence is more suitable to detect small metastatic lesions. Although [18F]NaF has been approved by U.S. FDA for a similar purpose, requirement of a medical cyclotron for its regular formulation restricts its extensive utilization. Efforts have been made to find suitable alternative molecules that can be labeled with 68Ga and used in PET-CT imaging.

Objective

The main objective of this study is to synthesize and evaluate a new [68Ga]Ga-labeled NOTA-conjugated geminal bisphosphonate for its potential use in early detection of skeletal metastases using PET-CT.

Methods

The authors performed a multistep synthesis of a new NOTA-conjugated bisphosphonic acid using thiourea linker and radiolabeled the molecule with 68Ga. The radiolabeled formulation was evaluated for its in vitro stability, affinity for hydroxyapatite (HA) particles, preclinical biodistribution in animal models, and PET-CT imaging in patients.

Results

The bifunctional chelator (NOTA)-conjugated bisphosphonate was synthesized with 97.8% purity and radiolabeled with 68Ga in high yield (>98%). The radiolabeled formulation was found to retain its stability in vitro to the extent of >95% up to 4 h in physiological saline and human serum. The formulation also showed high affinity for HA particles in vitro with Kd = 907 ± 14 mL/g. Preclinical biodistribution studies in normal Wistar rats demonstrated rapid and almost exclusive skeletal accumulation of the complex. PET-CT imaging in a patient confirmed its ability to detect small metastatic skeletal lesions.

Conclusions

The newly synthesized [68Ga]Ga-labeled NOTA-conjugated bisphosphonate is a promising radiotracer for PET-CT imaging for skeletal metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyGallium RadioisotopesHeterocyclic Compounds, 1-RingRatsAnimalsHumansDiphosphonatesTissue DistributionRats, WistarPositron-Emission TomographyQuality Control

Stichwörter der Autor:innen

68GaNOTAPETbifunctional chelatorbisphosphonatesbone metastases

Substanzen

1,4,7-triazacyclononane-N,N',N''-triacetic acidGallium RadioisotopesDiphosphonatesHeterocyclic Compounds, 1-Ring

Autor:innen und Institutionen

  • Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai, India.
  • Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Bio Organic Division, Bhabha Atomic Research Centre (BARC), Mumbai, India.
  • Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre (BARC), Mumbai, India.
  • Molecular Group of Companies, Ernakulam, India.

ORCID-Profile: Sudipta Chakraborty

Zitieren

APA

Chakraborty, S., Chatterjee, S., Chakravarty, R., Sarma, H. D., Nanabala, R., Goswami, D., Joy, A., & Pillai, M. R. A. (2024). Synthesis, Quality Control, and Bench-to-Bed Translation of a New [ 68 Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0077

Vancouver

Chakraborty S, Chatterjee S, Chakravarty R, Sarma HD, Nanabala R, Goswami D, et al. Synthesis, Quality Control, and Bench-to-Bed Translation of a New [ 68 Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0077

BibTeX
@article{Chakraborty2024,
  author = {Chakraborty, Sudipta and Chatterjee, Sucheta and Chakravarty, Rubel and Sarma, Haldhar D and Nanabala, Raviteja and Goswami, Dibakar and Joy, Ajith and Pillai, Maroor Raghavan Ambikalamajan},
  title = {Synthesis, Quality Control, and Bench-to-Bed Translation of a New [ 68 Ga]Ga-Labeled NOTA-Conjugated Bisphosphonate for Imaging Skeletal Metastases by Positron Emission Tomography},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2023.0077}
}
Kostenlos starten →